NEW YORK: Mylan N.V. and Pfizer Inc. announced that the U.S. Federal Trade Commission (FTC) has approved the proposed combination of Mylan and Pfizer’s Upjohn Business. The parties have now obtained all required antitrust clearances for the proposed transaction. The combination will be effected through a Reverse Morris Trust transaction, pursuant to which Upjohn Inc.…